BI(G)MED: epigenetic regulation at the heart of your cells
Chronic diseases now occupy a major place in human health, affecting functions as diverse as immunity, metabolism, and the nervous system. Their origin is not limited to genetic mutations: it often results from a dysregulation of gene expression, an epigenetic imbalance that profoundly alters cellular function. At the center of these adjustments are non-coding RNAs, true modulators of genetic activity. By acting on these fine regulations, Bio Immuno(G)enetic Medicine (BI(G)MED) offers a way to restore cellular homeostasis and restore the body’s self-healing capacities.
Our diagnostic approach
The BI(G)MED diagnostic approach is based on a precise reading of the immune system, persistent infections, and genetic predispositions. Lymphocyte typing, protein profiles, serology, and HLA genotyping make it possible to trace the deep mechanisms of biological imbalances. A gateway to truly causal medicine.
Our therapeutic approach
The BI(G)MED therapeutic approach is based on the fine regulation of gene expression through non-coding RNAs used at ultra-low doses. These physiological molecules restore cellular homeostasis and reactivate the natural self-regulation capacities of living organisms. An epigenetic, targeted, and biomimetic strategy.
Training in BI(G)MED
The EBMA association offers training courses in BioImmune(G)ene Medicine in French, German, and Spanish.
EBMA: who are we?
EBMA brings together those who wish to advance the understanding of living organisms through Bio Immuno(G)enetic Medicine (BI(G)MED).
The association supports healthcare professionals in discovering and mastering this approach by offering training, peer exchanges, and stimulating scientific meetings.
It also supports the emergence of new speakers and trainers, participates in conferences in Europe, and contributes to research by conducting studies and publishing in specialized journals.
Based in Colmar, EBMA now extends to Germany, Spain, Portugal, Belgium, Luxembourg, and Austria, driven by a committed and growing community.
BIGMED is a realistic and scientific possibility to treat the patient holistically and with possibilities for improvement, or even cure, of chronic diseases or those made chronic by conventional treatments. Professionally, I am enthusiastic and completely committed to BI(G)MED.
Dr. Begoña S.
Doctor
BI(G)MED has given me a more complete vision of disease and health and has completely transformed my medical practice. This highly individualized and precise method, which seeks the origin of disease, brings me great satisfaction in my daily practice as a physician. I can observe every day the enormous capacity of the body to defend itself against damage. I believe that BI(G)MED will change the way we approach and treat diseases in the future.
Dr. Inmaculada M.
Doctor
BI(G)MED currently represents between 50 and 90% of the treatments I prescribe to my patients, in addition to other methods (micronutrition, etc.). I have been practicing for 10 years (the early days of BI(G)MED) and have treated more patients with positive results than I can remember. One example among many: I recently managed to avoid the placement of a pacemaker in a 96-year-old patient with rhythm disorders, using a 100% BI(G)MED protocol! The cardiologist himself observed a complete normalization of the heart rhythm after a few weeks. The patient is no longer short of breath and has resumed her usual rhythm. In short, she is very happy, and so am I!
Ms. Ece A
Physician
Key figures
2010
Year BI(G)MED was created by Dr. Gilbert Glady, current president of EBMA.
+ 180
Regulatory formulas in all fields of health. These formulas are regularly updated according to advances in scientific discoveries.
+3000
Practitioners in Europe and around the world who have integrated BI(G)MED into their daily practice to support their patients.
+400 000
Patients who have regained the path to health through personalized support and adapted regulatory formulas.
Our latest articles
-
The importance of MicroRNA in the diagnosis and treatment of disease – Dr. I. Muñoz
FROM GENOME TO PROTEOME All of the information related to our bodies is contained in our DNA. Each gene comprises several elements: a transcription initiation site, a promotor region, a terminal so-called consensus sequence, exons and introns. The exons constitute the protein-coding regions. There are non-coding regions in the introns and intergenic sequences that regulate… -
New publication : BI(G)MED and SARS-CoV-2
It has been almost two years since the SARS-CoV-2 epidemic broke out and spread across the globe, sparing no country. The appearance of variants exposes populations to successive waves, and their attendant socio-economic problems. And the end does not seem anywhere near. Officially, research into effective treatments is lagging behind, and the fight against this…